grant

INTER-ETHNIC DIFFERENCES IN TOLERANCE OF ANTI-CANCER DRUGS [ 2008 - 2011 ]


Funded by National Health and Medical Research Council
Managed by The University of Sydney
Managed by University of Sydney
Provided by   National Health and Medical Research Council

Research Grant

[Cite as https://purl.org/au-research/grants/nhmrc/512533]

Researchers: Prof Stephen Clarke (Principal investigator) ,  Prof Andrew Mclachlan

Brief description In 2 previous studies we have shown that Asian cancer patients experience more side-effects than their Caucasian counterparts when treated with the same dose and schedule of treatment. This does not appear to be related to any difference in size. We wish to explain this difference as it may avoid Asian patients receiving overdoses of treatment. Possible causes include dietary and nutritional differences

Funding Amount $AUD 345,894.40

Funding Scheme NHMRC Project Grants

Notes Standard Project Grant

Click to explore relationships graph
Help

Related Organisations

Related People

Subjects
Anti-cancer drug | Biomedical and Clinical Sciences | Chemotherapy toxicity | Inter-ethnic differences | Medical Biochemistry - Inorganic Elements and Compounds | Medical Biochemistry and Metabolomics | Nutrition | Nutrition status | Pharmacogenomics | Pharmacokinetics | Pharmacology-toxicology | Phenotype-genotype correlation |
Identifiers
Viewed: [[ro.stat.viewed]]
Saved to MyRDA Save to MyRDA